PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers discover simple amoeba holds the key to better treatment for Alzheimer's

2014-01-24
(Press-News.org) Contact information: Sophia Haque
sophia.haque@rhul.ac.uk
01-784-443-552
Royal Holloway, University of London
Researchers discover simple amoeba holds the key to better treatment for Alzheimer's

Scientists have discovered the use of a simple single-celled amoeba to understand the function of human proteins in causing Alzheimer's disease.

The new study, published in the Journal of Cell Science today (Friday 24 January) by researchers at Royal Holloway, University of London and the Institute of Psychiatry King's College London, reveals how the amoeba will enable a better understanding of the function of these Alzheimer's disease-associated proteins in the cell without the need for testing on animals, with the ultimate aim of developing improved treatments for the degenerative disease.

Mutations in presenilin proteins cause inherited forms of Alzheimer's disease, and these proteins also play a major role in the age-related onset of the condition.

However, understanding the role of these proteins is difficult, since cells lacking the proteins are non-viable.

Presenilin proteins have been extensively analysed and animals are commonly used in this research area, but these experiments are problematic since deletion of the proteins in animal cells causes a loss of viability and blocks the development.

"This discovery allows us to examine the role for the human presenilin 1 protein, without the use of animal testing. It is amazing that so simple an organism lends itself to the study of such a complex disease," says Professor Robin Williams from the School of Biological Sciences at Royal Holloway.

"This work on the amoeba Dictyostelium shows we can successfully use this simple model to try to better understand the normal roles of other proteins and genes involved in Alzheimer's disease and other forms of neurodegeneration," added Dr Richard Killick from the Institute of Psychiatry King's College London.



INFORMATION:



ELSE PRESS RELEASES FROM THIS DATE:

Central Europeans already digested milk as well as us 1,000 years ago

2014-01-24
Back in the Middle Ages, Central Europeans were already capable of digesting milk, yoghurt and cheese just as well as us today. Researchers at the University of Zurich's Centre for ...

Generation blame: How age affects our views of anti-social behavior

2014-01-24
A study of interpretations of anti-social behaviour (ASB) found a significant gap between the views of different age groups - with older people more likely than younger people to interpret ...

Changing climate: How dust changed the face of the earth

2014-01-24
Bremerhaven/Germany, 24 January 2014. In spring 2010, ...

World's first magma-enhanced geothermal system created in Iceland

2014-01-24
RIVERSIDE, Calif. — In 2009, a borehole drilled at Krafla, ...

Using engineering plus evolutionary analyses to answer natural selection questions

2014-01-24
AMHERST, Mass. – Introducing a new approach that combines evolutionary and engineering analyses to identify the targets of natural selection, researchers ...

Various microstructures fabricated by a solvent-cast 3-D printing technique

2014-01-24
Various microstructures including straight filaments, layer-by-layer ...

Researchers discover potential drug targets for early onset glaucoma

2014-01-24
Using a novel high-throughput screening process, scientists have for the first time identified molecules with the potential to block the accumulation of a toxic eye protein that ...

National plan for preventing healthcare-associated infections shows progress

2014-01-24
Philadelphia, Pa. (January 23, 2014) – Independent evaluators have found that measurable ...

The lung microbiome: A new frontier in pulmonary medicine

2014-01-24
The Annals of the American Thoracic Society has released a comprehensive supplement on the 56th annual Thomas L. Petty Aspen Lung Conference entitled "The Lung Microbiome: A New Frontier in Pulmonary Medicine." ...

Moderate doses of radiation therapy to unaffected breast may prevent second breast cancers

2014-01-24
NEW YORK, NY (January 23, 2014) — Survivors of breast cancer have a one in ...

LAST 30 PRESS RELEASES:

Understanding emerges: MBL scientists visualize the creation of condensates

Discovery could give investigators a new tool in death investigations

Ultrasonic pest control to protect beehives

PFAS mixture disrupts normal placental development which is important for a healthy pregnancy

How sound moves on Mars

Increasing plant diversity in agricultural grasslands boosts yields, reducing reliance on fertilizer

Scientists uncover a new role for DNA loops in repairing genetic damage

AI chatbots can effectively sway voters – in either direction

Study reveals 'levers' driving the political persuasiveness of AI chatbots

'Tiny' tyrannosaurid, Nanotyrannus lancensis, was a distinctive species, not juvenile T. Rex

Scientists capture first detailed look inside droplet-like structures of compacted DNA

Return of the short (tyrant) king: A new paper by Dinosaur Institute researcher shows Nanotyrannus was not a juvenile T. Rex

New study confirms Nanotyrannus holotype was distinct species from T. rex

Carnegie Science names Michael Blanton 12th Observatories Director

From mice to humans in five years: Microglia replacement paving the way for neurodegenerative disease therapies

To treat long COVID, we must learn from historical chronic illnesses, medical researchers say

Volcanic eruptions set off a chain of events that brought the Black Death to Europe

Environmental science: Volcanic activity may have brought the Black Death to medieval Europe

Public trust in scientists for cancer information across political ideologies in the US

Adverse experiences, protective factors, and obesity in Latinx and Hispanic youths

Researchers identify bacterial enzyme that can cause fatal heart conditions with pneumonia infections

Single enzyme failure found to drive neuron loss in dementia

Sudden cardiac death risk falls in colorectal cancer, but disparities persist

From lab to clinic: CU Anschutz launches Phase 1 clinical trial of promising combination therapy for resistant ovarian cancer

Renuka Iyer, MD, named new Chief Medical Officer for National Comprehensive Cancer Network (NCCN)

New organ-on-a-chip platform allows the testing of cancer vaccine efficacy in aging populations

No, we don't need more and more data about nature. We need more people to use the data

Research explores effect of parental depression symptoms on children’s reward processing

Phonetic or morpholexical issues? New study reveals L2 French ambiguity

Seeing inside smart gels: scientists capture dynamic behavior under stress

[Press-News.org] Researchers discover simple amoeba holds the key to better treatment for Alzheimer's